Klotho Neurosciences Files 8-K for Material Agreement
Ticker: GRMLW · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1907223
Sentiment: neutral
Topics: material-agreement, corporate-actions, filing
Related Tickers: KLTO
TL;DR
Klotho Neurosciences (KLTO) signed a material definitive agreement on 3/26/25. 8-K filed 4/1/25.
AI Summary
Klotho Neurosciences, Inc. filed an 8-K on April 1, 2025, reporting a material definitive agreement entered into on March 26, 2025. The filing also includes financial statements and exhibits. The company was formerly known as ANEW Medical, Inc. and Redwoods Acquisition Corp.
Why It Matters
This filing indicates a significant new agreement for Klotho Neurosciences, which could impact its business operations and financial standing. Investors should monitor for details on the nature of this agreement.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, and the lack of specific details in this initial filing warrants a medium risk assessment.
Key Players & Entities
- Klotho Neurosciences, Inc. (company) — Registrant
- March 26, 2025 (date) — Date of earliest event reported
- April 1, 2025 (date) — Date of report
- ANEW Medical, Inc. (company) — Former company name
- Redwoods Acquisition Corp. (company) — Former company name
FAQ
What is the nature of the material definitive agreement entered into by Klotho Neurosciences?
The filing does not specify the details of the material definitive agreement, only that one was entered into on March 26, 2025.
When was the 8-K filing submitted?
The 8-K filing was submitted on April 1, 2025.
What were Klotho Neurosciences' previous names?
Klotho Neurosciences, Inc. was formerly known as ANEW Medical, Inc. and Redwoods Acquisition Corp.
What is the company's state of incorporation?
The company is incorporated in Delaware.
What is the company's primary business classification?
The company's Standard Industrial Classification is Biological Products (No Diagnostic Substances) [2836].
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding Klotho Neurosciences, Inc. (GRMLW).